IHH Healthcare Seen as Defensive Play Despite Policy Risks -- Market Talk

Dow Jones

Jan 27

0219 GMT - IHH Healthcare is seen as an "effective hedge" against rising policy intervention in Malaysia's private healthcare sector, supported by its geographically diversified earnings, RHB IB analyst Eddy Do says in a note. Valuations and earnings are still expected to grow despite slower growth in constant currency terms in 2026, though reported growth may be weighed by a stronger ringgit, he says. IHH's disciplined execution, regional footprint and focus on higher-income patients should support earnings resilience. Do raises his 2025-2027 earnings estimates on IHH by 4%, 2% and 2.7%, respectively, to factor in a better margin outlook. RHB raises IHH's target price to MYR9.52 from MYR9.14 and maintains a buy rating on the stock. Shares are 0.7% higher at MYR8.72. (yingxian.wong@wsj.com)

(END) Dow Jones Newswires

January 26, 2026 21:19 ET (02:19 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2606763552"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2606763552\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2606763552?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-27 10:19","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2606763552","market":"hk","top_or_hot":-1,"title":"IHH Healthcare Seen as Defensive Play Despite Policy Risks -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0219 GMT - IHH Healthcare is seen as an \"effective hedge\" against rising policy intervention in Malaysia's private healthcare sector, supported by its geographically diversified earnings, RHB IB analyst Eddy Do says in a note. Valuations and earnings are still expected to grow despite slower growth in constant currency terms in 2026, though reported growth may be weighed by a stronger ringgit, he says. IHH's disciplined execution, regional footprint and focus on higher-income patients should support earnings resilience. Do raises his 2025-2027 earnings estimates on IHH by 4%, 2% and 2.7%, respectively, to factor in a better margin outlook. RHB raises IHH's target price to MYR9.52 from MYR9.14 and maintains a buy rating on the stock. Shares are 0.7% higher at MYR8.72. (yingxian.wong@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 26, 2026 21:19 ET (02:19 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>IHH Healthcare Seen as Defensive Play Despite Policy Risks -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIHH Healthcare Seen as Defensive Play Despite Policy Risks -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-01-27 10:19</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0219 GMT - IHH Healthcare is seen as an \"effective hedge\" against rising policy intervention in Malaysia's private healthcare sector, supported by its geographically diversified earnings, RHB IB analyst Eddy Do says in a note. Valuations and earnings are still expected to grow despite slower growth in constant currency terms in 2026, though reported growth may be weighed by a stronger ringgit, he says. IHH's disciplined execution, regional footprint and focus on higher-income patients should support earnings resilience. Do raises his 2025-2027 earnings estimates on IHH by 4%, 2% and 2.7%, respectively, to factor in a better margin outlook. RHB raises IHH's target price to MYR9.52 from MYR9.14 and maintains a buy rating on the stock. Shares are 0.7% higher at MYR8.72. (yingxian.wong@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 26, 2026 21:19 ET (02:19 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4581","symbol_name":"高盛持仓","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2606763552","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2606763552","pubTimestamp":1769480340,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"0219 GMT - IHH Healthcare is seen as an \"effective hedge\" against rising policy intervention in Malaysia's private healthcare sector, supported by its geographically diversified earnings, RHB IB analyst Eddy Do says in a note. Valuations and earnings are still expected to grow despite slower growth in constant currency terms in 2026, though reported growth may be weighed by a stronger ringgit, he says. IHH's disciplined execution, regional footprint and focus on higher-income patients should support earnings resilience. Do raises his 2025-2027 earnings estimates on IHH by 4%, 2% and 2.7%, respectively, to factor in a better margin outlook. RHB raises IHH's target price to MYR9.52 from MYR9.14 and maintains a buy rating on the stock. Shares are 0.7% higher at MYR8.72. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4581":"高盛持仓","HCSG":"Healthcare Svcs Group Inc","Q0F.SI":"IHH医疗保健集团","LABU":"三倍做多标普生物-Direxion","BK4137":"综合支持服务","LU0128526141.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" ACC","BK6511":"医疗保健服务概念","LU0029874061.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" YDIS INC","BK4588":"碎股","XBI":"SPDR S&P Biotech ETF","BK4585":"ETF&股票定投概念","BK6092":"保健护理机构","XLV":"健康照护类股ETF-SPDR"},"translate_title":"尽管存在政策风险，IHH医疗保健仍被视为防御性投资——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XLV":1.5,"XBI":0.6,"LABU":0.6,"HCSG":1.5,"Q0F.SI":0.73},"content_text":"0219 GMT - IHH Healthcare is seen as an \"effective hedge\" against rising policy intervention in Malaysia's private healthcare sector, supported by its geographically diversified earnings, RHB IB analyst Eddy Do says in a note. Valuations and earnings are still expected to grow despite slower growth in constant currency terms in 2026, though reported growth may be weighed by a stronger ringgit, he says. IHH's disciplined execution, regional footprint and focus on higher-income patients should support earnings resilience. Do raises his 2025-2027 earnings estimates on IHH by 4%, 2% and 2.7%, respectively, to factor in a better margin outlook. RHB raises IHH's target price to MYR9.52 from MYR9.14 and maintains a buy rating on the stock. Shares are 0.7% higher at MYR8.72. (yingxian.wong@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 26, 2026 21:19 ET (02:19 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}